108 related articles for article (PubMed ID: 12766968)
1. Analysis of P-glycoprotein-mediated membrane transport in human peripheral blood lymphocytes using the UIC2 shift assay.
Park SW; Lomri N; Simeoni LA; Fruehauf JP; Mechetner E
Cytometry A; 2003 Jun; 53(2):67-78. PubMed ID: 12766968
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes.
Raghu G; Park SW; Roninson IB; Mechetner EB
Exp Hematol; 1996 Aug; 24(10):1258-64. PubMed ID: 8765502
[TBL] [Abstract][Full Text] [Related]
3. Quantitative and functional assay of MDR1/P170-mediated MDR in ascites cells of patients with ovarian cancer.
Krasznai ZT; Friedländer E; Nagy A; Szabó G; Vereb G; Goda K; Hernádi Z
Anticancer Res; 2005; 25(2A):1187-92. PubMed ID: 15868961
[TBL] [Abstract][Full Text] [Related]
4. Binding diversity of antibodies against external and internal epitopes of the multidrug resistance gene product P-glycoprotein.
Lehne G; De Angelis P; Clausen OP; Egeland T; Tsuruo T; Rugstad HE
Cytometry; 1995 Jul; 20(3):228-37. PubMed ID: 7587708
[TBL] [Abstract][Full Text] [Related]
5. Detection of the MDR1 P-glycoprotein expression and function.
Mechetner E
Methods Mol Biol; 2007; 378():175-93. PubMed ID: 18605086
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein-mediated efflux of indinavir metabolites in Caco-2 cells expressing cytochrome P450 3A4.
Hochman JH; Chiba M; Yamazaki M; Tang C; Lin JH
J Pharmacol Exp Ther; 2001 Jul; 298(1):323-30. PubMed ID: 11408558
[TBL] [Abstract][Full Text] [Related]
7. Evidence that the choroids plexus in female sheep express P-glycoprotein.
Bougoin S; Lomet D; Kerboeuf D; Le Vern Y; Malpaux B; Thiery JC
Neuro Endocrinol Lett; 2008 Aug; 29(4):438-42. PubMed ID: 18766153
[TBL] [Abstract][Full Text] [Related]
8. Conformational heterogeneity of P-glycoprotein.
Goda K; Nagy H; Bene L; Balázs M; Arceci R; Mechetner E; Szabó G
Cancer Detect Prev; 2000; 24(5):415-21. PubMed ID: 11129983
[TBL] [Abstract][Full Text] [Related]
9. Influence of beta-adrenergic antagonists, H1-receptor blockers, analgesics, diuretics, and quinolone antibiotics on the cellular accumulation of the anticancer drug, daunorubicin: P-glycoprotein modulation.
Ibrahim S; Peggins J; Knapton A; Licht T; Aszalos A
Anticancer Res; 2001; 21(2A):847-56. PubMed ID: 11396174
[TBL] [Abstract][Full Text] [Related]
10. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
[TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein-mediated colchicine resistance in different cell lines correlates with the effects of colchicine on P-glycoprotein conformation.
Druley TE; Stein WD; Ruth A; Roninson IB
Biochemistry; 2001 Apr; 40(14):4323-31. PubMed ID: 11284688
[TBL] [Abstract][Full Text] [Related]
12. Utility of unbound plasma drug levels and P-glycoprotein transport data in prediction of central nervous system exposure.
He H; Lyons KA; Shen X; Yao Z; Bleasby K; Chan G; Hafey M; Li X; Xu S; Salituro GM; Cohen LH; Tang W
Xenobiotica; 2009 Sep; 39(9):687-93. PubMed ID: 19569734
[TBL] [Abstract][Full Text] [Related]
13. [Assessment of P glycoprotein expression by immunocytochemistry and flow cytometry coupled with functional efflux analysis: application to acute myeloid leukemia].
Poulain S; Lepelley P; Cambier N; Wattel E; Fenaux P; Cosson A
Ann Biol Clin (Paris); 1999; 57(5):595-600. PubMed ID: 10518062
[TBL] [Abstract][Full Text] [Related]
14. Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Nagy H; Goda K; Fenyvesi F; Bacsó Z; Szilasi M; Kappelmayer J; Lustyik G; Cianfriglia M; Szabó G
Biochem Biophys Res Commun; 2004 Mar; 315(4):942-9. PubMed ID: 14985103
[TBL] [Abstract][Full Text] [Related]
15. The anti-inflammatory effects of inhaled corticosteroids versus anti-leukotrienes on the lymphocyte P-glycoprotein (PGP) expression in asthmatic children.
Kopriva F; Dzubak P; Potesil J; Hajduch M
J Asthma; 2009 May; 46(4):366-70. PubMed ID: 19484671
[TBL] [Abstract][Full Text] [Related]
16. Complete inhibition of P-glycoprotein by simultaneous treatment with a distinct class of modulators and the UIC2 monoclonal antibody.
Goda K; Fenyvesi F; Bacsó Z; Nagy H; Márián T; Megyeri A; Krasznai Z; Juhász I; Vecsernyés M; Szabó G
J Pharmacol Exp Ther; 2007 Jan; 320(1):81-8. PubMed ID: 17050779
[TBL] [Abstract][Full Text] [Related]
17. Several major antiepileptic drugs are substrates for human P-glycoprotein.
Luna-Tortós C; Fedrowitz M; Löscher W
Neuropharmacology; 2008 Dec; 55(8):1364-75. PubMed ID: 18824002
[TBL] [Abstract][Full Text] [Related]
18. Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody.
Mechetner EB; Roninson IB
Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5824-8. PubMed ID: 1352877
[TBL] [Abstract][Full Text] [Related]
19. Novel multiparameter flow cytometry assay using Syto16 for the simultaneous detection of early apoptosis and apoptosis-corrected P-glycoprotein function in clinical samples.
van der Pol MA; Broxterman HJ; Westra G; Ossenkoppele GJ; Schuurhuis GJ
Cytometry B Clin Cytom; 2003 Sep; 55(1):14-21. PubMed ID: 12949955
[TBL] [Abstract][Full Text] [Related]
20. (+/-)-3'-O, 4'-O-dicynnamoyl-cis-khellactone, a derivative of (+/-)-praeruptorin A, reverses P-glycoprotein mediated multidrug resistance in cancer cells.
Shen X; Chen G; Zhu G; Fong WF
Bioorg Med Chem; 2006 Nov; 14(21):7138-45. PubMed ID: 16875827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
